Kristen M Pettit
Clinical Associate Professor of Internal Medicine

Available to mentor
Kristen M Pettit
Clinical Associate Professor
  • Center Memberships
  • Recent Publications
    • Center Memberships
    • Center Member
      Rogel Cancer Center
    Recent Publications See All Publications
    • Journal Article
      Exploring Adolescent and Young Adult Cancer Survivors' Experience with Cancer Treatment-Related Symptoms: A Qualitative Analysis of Semi-Structured Interviews.
      Knoerl R, Grandinetti K, Smener L, Doll E, Fecher LA, Henry NL, Karimi Y, Pettit K, Schuetze S, Walling E, Zhang A, Barton D. J Adolesc Young Adult Oncol, 2024 Aug; 13 (4): 665 - 673. DOI:10.1089/jayao.2024.0053
      PMID: 38634665
    • Journal Article
      Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era.
      Patel AA, Yoon JJ, Johnston H, Davidson MB, Shallis RM, Chen EC, Burkart M, Oh TS, Iyer SG, Madarang E, Muthiah C, Gross I, Dean R, Kassner J, Viswabandya A, Madero-Marroquin R, Rampal RK, Guru Murthy GS, Bradley T, Abaza Y, Garcia JS, Gupta V, Pettit KM, Cursio JF, Odenike O. Blood Adv, 2024 Jul 9; 8 (13): 3468 - 3477. DOI:10.1182/bloodadvances.2024012880
      PMID: 38739724
    • Journal Article
      Phase 2 study of the lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in patients with polycythemia vera (PV).
      Rinaldi C, Rein L, Livings A, Innes AJ, Pettit K, Yeh P, Larsen SR, Watson A-M, Leahy MF, Curto-Garcia N, Mahdi A, Frewin R, Qureshi H, Shatzel J, Vaughn J, Tashi T, Amin H, Ogbu U, Gumuscu B, Ross DM. Journal of Clinical Oncology, 2024 Jun 1; 42 (16_suppl): tps6595 - tps6595. DOI:10.1200/jco.2024.42.16_suppl.tps6595
    • Journal Article
      Quantitative MRI reveals heterogeneous impacts of treatment on diseased bone marrow in a mouse model of myelofibrosis.
      Robison TH, Lee W, Luker KE, Pettit K, Talpaz M, Chenevert TL, Ross BD, Luker GD. Magn Reson Med, 2024 Jun; 91 (6): 2568 - 2578. DOI:10.1002/mrm.30016
      PMID: 38265182
    • Journal Article
      VERIFY: A randomized controlled phase 3 study of the hepcidin mimetic rusfertide (PTG-300) in patients with polycythemia vera (PV).
      Bankar A, Pettit K, Shatzel J, Yacoub A, Pemmaraju N, Gill H, Hlusi A, Lucchesi A, Alimam S, Mayer J, Palandri F, Sasca D, Modelska K, Gupta SK, Ajari I, Khanna S, Molina A, Kuykendall AT. Journal of Clinical Oncology, 2024 Jun 1; 42 (16_suppl): tps6592 - tps6592. DOI:10.1200/jco.2024.42.16_suppl.tps6592
    • Journal Article
      Broad Next-Generation Integrated Sequencing of Myelofibrosis Identifies Disease-Specific and Age-Related Genomic Alterations.
      Kandarpa M, Robinson D, Wu Y-M, Qin T, Pettit K, Li Q, Luker G, Sartor M, Chinnaiyan A, Talpaz M. Clin Cancer Res, 2024 May 1; 30 (9): 1972 - 1983. DOI:10.1158/1078-0432.CCR-23-0372
      PMID: 38386293
    • Additional Scholarship
      Data from Broad Next-Generation Integrated Sequencing of Myelofibrosis Identifies Disease-Specific and Age-Related Genomic Alterations
      Kandarpa M, Robinson D, Wu Y-M, Qin T, Pettit K, Li Q, Luker G, Sartor M, Chinnaiyan A, Talpaz M. 2024 May 1; DOI:10.1158/1078-0432.c.7209134.v1
    • Additional Scholarship
      Supplemental Table 8 from Broad Next-Generation Integrated Sequencing of Myelofibrosis Identifies Disease-Specific and Age-Related Genomic Alterations
      Kandarpa M, Robinson D, Wu Y-M, Qin T, Pettit K, Li Q, Luker G, Sartor M, Chinnaiyan A, Talpaz M. 2024 May 1; DOI:10.1158/1078-0432.25728686